Bristol-Myers Squibb Co (NYSE: BMY) is making a run for the top in the market this morning after announcing positive clinical data. The data comes… Read More »Bristol-Myers Squibb (BMY) Stock Pops On Positive Data
Investing in biotech stocks can be tricky. Clinical-stage companies are often underfunded and over-speculated. Those that do have products on the market and are doing… Read More »Biotech Stocks Are Rarely This Undervalued
The biotech space has been one that has garnered incredible attention as of late, and for good reason. The truth of the matter is that… Read More »Interested In Biotech Stocks? Take A Close Look At Spherix (SPEX) Stock!
Rumors are breaking surroundng Bristol-Myers Squibb Co (NYSE: BMY), and while they aren’t quite moving the market yet, should the rumors be true, the stock… Read More »Bristol-Myers Squibb (BMY) Stock May Be Acquired By Pfizer (PFE)